The first Biden-era vaccine against Covid-19 is moving toward market, but new bumps could trip up the big launch

The Biden administration is relishing the chance to put its new-and-improved distribution program on display with the release of the forthcoming Johnson & Johnson vaccine, but problems are threatening a smooth rollout — including a slower-than-expected production timeline and a lack of information about when and how the shots will made available.